drugset / Trial / NCT01097681
A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment
Non-randomizedParallel-groupOpen-labelOther
Summary
The primary objective of this study is to compare the pharmacokinetics of ASP1941 in type 2 diabetes mellitus patients with normal renal function and those with mild or moderate renal impairment.
Timeline
- Start
- 2010-02-16
- Primary completion
- 2010-06-18
- Completion
- 2010-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ipragliflozin | Small molecule | — | Oral |